1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > MediPoint: Prosthetic Heart Valves - APAC Analysis and Market Forecasts

MediPoint: Prosthetic Heart Valves - APAC Analysis and Market Forecasts

  • February 2015
  • -
  • GlobalData

Summary

Table of Contents

MediPoint: Prosthetic Heart Valves - APAC Analysis and Market Forecasts

Summary

The Asia-Pacific (APAC) prosthetic heart valves (PHV) market is a dynamic market that is expected to grow through 2020. Recent advancements in the field of interventional cardiology have greatly improved clinical outcomes for patients. Prosthetic heart valves, including mechanical valves, tissue valves, and transcatheter valves, can be used to treat patients with valvular heart disease affecting the aortic or mitral valves. They can be delivered either via open-heart surgery or transcatheter aortic valve implantation (TAVR).

The PHV market in the APAC region is determined for three major APAC markets: Japan, China, and India. The report provides insights into the competitive landscape, the marketed and pipeline products, the current and emerging players and market analysis of the different device segments within the PHV market in the APAC region. The report also provides insight into the unmet needs and an understanding of physician perceptions and decision-making process in using prosthetic heart valves. This report is built using data and information sourced from secondary sources and primary research interviews with leading Interventional Cardiologists, with in-house analysis conducted by GlobalData’s team of industry experts.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Questions Answered

- What is the current and future prosthetic heart valves market outlook in the APAC region? What trends are affecting these markets?
- Which are the key, high growth markets that valve manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with PHVs currently on the market? How will emerging technologies such as repositionable and retrievable valves fulfill these unmet needs?
- What clinical factors and technical specifications influence a physician to use one type of valve over another? What is physician perception and market outlook of PHV?
- What are the challenges and complications of TAVR that have hindered widespread adoption?
- With developing the next-generation of heart valves, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the PHV market?

Key Benefits

“What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading Interventional Cardiologists and Cardiac Surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Scope

- Overview of valvular heart disease, including anatomy, epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
- Annualized total PHV market revenue from 2011-2020 including adoption patterns in the APAC region.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, and implications for the PHV market.
- Pipeline analysis: Comprehensive list of products split across different stages of development, emerging trends and valve designs in development, including investigation of delivery and deployment methods, materials and coatings used, and sizes available.
- Analysis of the current and future market competition in the APAC PHV market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- Understand the trends shaping and driving the APAC PHV market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in APAC PHV market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in APAC PHV market landscape? Identify, understand and capitalize.

Please note: this report requires certain updates. We have all the information available but require 4 business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...


Download Unlimited Documents from Trusted Public Sources

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Biochemical Supply

  • April 2017
    2 pages
  • Biochemical  

    Biopharmaceutic...  

    Bioprocessing  

  • Europe  

    Portugal  

    United Kingdom  

View report >

In Vitro Diagnostic Reagent Supply in Japan

  • April 2017
    2 pages
  • In Vitro Diagno...  

  • Japan  

    Asia  

    China  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.